Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
New Post
White House Issues Executive Order “Pausing” FCPA Enforcement—But Beware
February 14, 2025
Insight
New Post
Attorney General Bondi’s Opening Salvo: Implications for FCPA and Beyond
February 6, 2025
Insight
DOJ announces transfer of more than $50 million in forfeited corruption proceeds to Nigerian government
January 16, 2025
News Alert